India’s proposed massive National Health Protection Scheme (NHPS), which hopes to cover 100 million “poor and vulnerable” families with health cover of up to INR500,000 ($7,805) each annually for secondary and tertiary care hospitalization, is expected to facilitate significant market expansion.
Pharma industry executives anticipate a sharp expansion of demand for medicines in India, though pricing-related disturbances could stunt gains for...







